[Mechanisms of interactions of anti-arrhythmia agents during their combined use].
Adnan Abdalla
Mazur
N A
NA
Shestakova
N V
NV
D000638:Amiodarone / Q000008:administration & dosage / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004077:Digoxin / Q000008:administration & dosage / Q000494:pharmacology; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D011188:Potassium / Q000008:administration & dosage / Q000494:pharmacology; D011342:Procainamide / Q000008:administration & dosage / Q000494:pharmacology; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology; D011802:Quinidine / Q000008:administration & dosage / Q000494:pharmacology; D014700:Verapamil / Q000008:administration & dosage / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D004077:Digoxin; D011433:Propranolol; D014700:Verapamil; D011802:Quinidine; D011342:Procainamide; D000638:Amiodarone; D011188:Potassium
Mekhanizmy vzaimodeĭstviia antiaritmicheskikh preparatov pri ikh kombinirovannom primenenii.